REBOUND ATOPIC DERMATITIS

This adverse event was reported 2029 times

REBOUND ATOPIC DERMATITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-4 Receptor alpha Antagonist [EPC] 2022 0.0046
1 Pyrethroid [EPC] 2 0.0012
2 Interleukin-13 Antagonist [EPC] 6 0.0009
3 Aryl Hydrocarbon Receptor Agonist [EPC] 1 0.0006
4 Interleukin-31 Receptor alpha Antagonist [EPC] 5 0.0005
5 alpha-Hydroxy Acid [EPC] 1 0.0005
6 Ectoparasiticide [EPC] 1 0.0004
7 Antiparasitic [EPC] 2 0.0003
8 Pediculicide [EPC] 2 0.0003
9 Catecholamine [EPC] 20 0.0003
See all drug classes enriched for association with REBOUND ATOPIC DERMATITIS